Citation Impact
Citing Papers
Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models
2016
B7-1/2 (CD80/CD86) Direct Signaling to B Cells Enhances IgG Secretion
2009
HIF-independent synthetic lethality between CDK4/6 inhibition and VHL loss across species
2019 StandoutNobel
CDK4 deficiency promotes genomic instability and enhances Myc-driven lymphomagenesis
2014
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Type I interferons in infectious disease
2015 Standout
Coordinated regulation of myeloid cells by tumours
2012 Standout
CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity
2019 StandoutNobel
Targeting B cell receptor signalling in cancer: preclinical and clinical advances
2018
Toll‐like receptors – sentries in the B‐cell response
2009
Inflammation and Colon Cancer
2010 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Targeting apoptosis in cancer therapy
2020 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Broadening horizons: the role of ferroptosis in cancer
2021 Standout
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
BCL-2 family isoforms in apoptosis and cancer
2019 Standout
Tumor microenvironment is multifaceted
2011
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Postallograft lenalidomide induces strong NK cell–mediated antimyeloma activity and risk for T cell–mediated GvHD: Results from a phase I/II dose-finding study
2012
Macrophage M1/M2 polarization
2020 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Strong coupling between surface plasmon polaritons and emitters: a review
2014 Standout
Single human B cell-derived monoclonal anti-Candida antibodies enhance phagocytosis and protect against disseminated candidiasis
2018
Endogenous toll‐like receptor ligands and their biological significance
2010
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Diabetes and Cancer
2010 Standout
Fast Rescoring Protocols to Improve the Performance of Structure-Based Virtual Screening Performed on Protein–Protein Interfaces
2020
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
PubChem 2023 update
2022 Standout
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Found in Translation: How Preclinical Research Is Guiding the Clinical Development of the BCL2-Selective Inhibitor Venetoclax
2017
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
2014 Standout
Targeting CDK4 and CDK6: From Discovery to Therapy
2015
Survey of the 2009 commercial optical biosensor literature
2011
Microglial M1/M2 polarization and metabolic states
2015 Standout
The Concise Guide to PHARMACOLOGY 2013/14: Catalytic Receptors
2013
PubChem in 2021: new data content and improved web interfaces
2020 Standout
Works of David Chiron being referenced
Cell-Cycle Reprogramming for PI3K Inhibition Overrides a Relapse-Specific C481S BTK Mutation Revealed by Longitudinal Functional Genomics in Mantle Cell Lymphoma
2014
TLR9 Ligand Induces the Generation of CD20+ Plasmablasts and Plasma Cells from CD27+ Memory B-Cells
2011
Induction of prolonged early G1arrest by CDK4/CDK6 inhibition reprograms lymphoma cells for durable PI3Kδ inhibition through PIK3IP1
2013
CSF1R and BTK inhibitions as novel strategies to disrupt the dialog between mantle cell lymphoma and macrophages
2019
Rational targeted therapies to overcome microenvironment-dependent expansion of mantle cell lymphoma
2016
Toll-like receptors: lessons to learn from normal and malignant human B cells
2008
Phosphorothioate-Modified TLR9 Ligands Protect Cancer Cells against TRAIL-Induced Apoptosis
2009
Toll-like receptors: Expression and involvement in Multiple Myeloma
2010
Biological rational for sequential targeting of Bruton tyrosine kinase and Bcl-2 to overcome CD40-induced ABT-199 resistance in mantle cell lymphoma
2015
Restoring Apoptosis with BH3 Mimetics in Mature B-Cell Malignancies
2020
TLR3 Ligand Induces NF-κB Activation and Various Fates of Multiple Myeloma Cells Depending on IFN-α Production
2009